A5033163362- COVID-19 Clinical Research Studies
- Systemic Lupus Erythematosus Research
- Liver Disease Diagnosis and Treatment
- Health and Lifestyle Studies
- Diabetes and associated disorders
- Galectins and Cancer Biology
- Monoclonal and Polyclonal Antibodies Research
- Drug-Induced Hepatotoxicity and Protection
- Cytokine Signaling Pathways and Interactions
- COVID-19 and healthcare impacts
- COVID-19 and Mental Health
- Pancreatitis Pathology and Treatment
- Public Health and Environmental Issues
Hospital Central Militar
2020-2022
Secretaría de la Defensa Nacional
2022
Abstract Patients with pre‐existing liver diseases are considered to have an increased risk of morbidity and mortality from any type infection, including viruses. The aim this work was explore the implications metabolic dysfunction‐associated fatty disease (MAFLD) nonalcoholic (NAFLD) definitions in coronavirus 2019 (COVID‐19) study interaction between advanced fibrosis (AF) each these death intubation patients hospitalized COVID‐19. We performed a retrospective 359 confirmed COVID‐19...
COVID-19, caused by the betacoronavirus SARS-CoV-2, has overwhelmed world's health systems.To describe epidemiological characteristics of patients treated in a tertiary care hospital.A retrospective cohort study diagnosed with or suspected having COVID-19 from March 23 to July 31, 2020 was conducted.4,401 were hospitalized at Central Military Hospital, out which 35 % beneficiaries, 26 civilians, 28 active military personnel, and only 11 %, retired personnel. Male gender predominated, both...
Introduction: COVID-19, caused by the betacoronavirus SARS-CoV-2, has overwhelmed world's health systems.Objective: To describe epidemiological characteristics of patients treated in a tertiary care hospital.Methods: A retrospective cohort study diagnosed with or suspected having COVID-19 from March 23 to July 31, 2020 was conducted.Results: 4,401 were hospitalized at Central Military Hospital, out which 35 % beneficiaries, 26 civilians, 28 active military personnel, and only 11 %, retired...
Background and aim: Recent studies on SARS-CoV-2 have shown that the incidence of liver injury varies between 14.8% 53%, mainly demonstrable by abnormal ALT / AST levels accompanied slightly elevated bilirubin levels. Reports autopsies around word patients death from COVID-19 shows severe damage ranging 58.06% to 78% cases. There is evidence elevation transaminases (ALT AST) translates into a more serious clinical profile. Besides, related with high risk mortality, so it must be monitored...